|
Diabetes Care, Vol 19, Issue 8 795-800, Copyright © 1996 by American Diabetes Association
Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group
J Ilonen, H Reijonen, E Herva, M Sjoroos, A Iitia, T Lovgren, R Veijola, M Knip and HK Akerblom
Turku Immunology Center, University of Turku, Finland.
OBJECTIVE: To study the effectiveness of MHC genotyping in the assessment
of risk for IDDM based on the identification of alleles that are
significantly associated with risk for IDDM (DQB1 *0302 and *0201) and
protection from it (DQB1 *0602/*0603 and *0301). RESEARCH DESIGN AND
METHODS: A long series of 649 index cases of IDDM, together with their
healthy siblings and 756 healthy blood donors, was collected in Finland.
The samples were analyzed using a large-scale assay procedure that was
developed for rapid screening purposes. The method utilizes time-resolved
fluorometry to detect the hybridization of lanthanide-labeled
allele-specific oligonucleotide probes with amplified gene product.
RESULTS: A total of 61.9% of IDDM index cases had high risk (DQB1
*0201/*0302) or moderate risk (DQB1 *0302/x [x meaning DQB1 *0302 or a
nondefined allele]) genotypes compared with 14.3% of the reference
population. In patients and control subjects, the frequencies of low risk
genotypes were 28.0 and 22.1%, respectively, and those of decreased risk
genotypes, 10.0 and 63.6%. The relative risk of a *0201/*0302 genotype was
53.5 (31.1-92.8) compared with the decreased risk genotypes (63.6% of
controls). The graded risk estimation was equally efficient in assessing
the risk of IDDM in siblings of child with IDDM. CONCLUSION: The
near-automatic typing procedure developed is attractive for large-scale
screening projects, such as diabetes prevention and intervention trials.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Uusitalo, M. G Kenward, S. M Virtanen, U. Uusitalo, J. Nevalainen, S. Niinisto, C. Kronberg-Kippila, M.-L. Ovaskainen, L. Marjamaki, O. Simell, et al.
Intake of antioxidant vitamins and trace elements during pregnancy and risk of advanced {beta} cell autoimmunity in the child
Am. J. Clinical Nutrition,
August 1, 2008;
88(2):
458 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cervin, V. Lyssenko, E. Bakhtadze, E. Lindholm, P. Nilsson, T. Tuomi, C. M. Cilio, and L. Groop
Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes
Diabetes,
May 1, 2008;
57(5):
1433 - 1437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Knip
Should We Screen for Risk of Type 1 Diabetes?
Diabetes Care,
March 1, 2008;
31(3):
622 - 623.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kukko, S. M. Virtanen, A. Toivonen, S. Simell, S. Korhonen, J. Ilonen, O. Simel, and M. Knip
Geographical Variation in Risk HLA-DQB1 Genotypes for Type 1 Diabetes and Signs of {beta}-Cell Autoimmunity in a High-Incidence Country
Diabetes Care,
March 1, 2004;
27(3):
676 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M Virtanen and M. Knip
Nutritional risk predictors of {beta} cell autoimmunity and type 1 diabetes at a young age
Am. J. Clinical Nutrition,
December 1, 2003;
78(6):
1053 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mrena, K. Savola, P. Kulmala, H. Reijonen, J. Ilonen, H. K. Akerblom, and M. Knip
Genetic Modification of Risk Assessment Based on Staging of Preclinical Type 1 Diabetes in Siblings of Affected Children
J. Clin. Endocrinol. Metab.,
June 1, 2003;
88(6):
2682 - 2689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimpimaki, P. Kulmala, K. Savola, A. Kupila, S. Korhonen, T. Simell, J. Ilonen, O. Simell, and M. Knip
Natural History of {beta}-Cell Autoimmunity in Young Children with Increased Genetic Susceptibility to Type 1 Diabetes Recruited from the General Population
J. Clin. Endocrinol. Metab.,
October 1, 2002;
87(10):
4572 - 4579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kupila, P. Keskinen, T. Simell, S. Erkkila, P. Arvilommi, S. Korhonen, T. Kimpimaki, M. Sjoroos, M. Ronkainen, J. Ilonen, et al.
Genetic Risk Determines the Emergence of Diabetes-Associated Autoantibodies in Young Children
Diabetes,
March 1, 2002;
51(3):
646 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimpimaki, A. Kupila, A.-M. Hamalainen, M. Kukko, P. Kulmala, K. Savola, T. Simell, P. Keskinen, J. Ilonen, O. Simell, et al.
The First Signs of {beta}-Cell Autoimmunity Appear in Infancy in Genetically Susceptible Children from the General Population: The Finnish Type 1 Diabetes Prediction and Prevention Study
J. Clin. Endocrinol. Metab.,
October 1, 2001;
86(10):
4782 - 4788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Santos, F. Perez-Bravo, E. Carrasco, M. Calvillan, and C. Albala
Association between HLA-DQB1 Alleles and Type 1 Diabetes in a Case-Parents Study Conducted in Santiago, Chile
Am. J. Epidemiol.,
April 15, 2001;
153(8):
794 - 798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimpimäki, P. Kulmala, K. Savola, P. Vähäsalo, H. Reijonen, J. Ilonen, H. K. Åkerblom, and M. Knip
Disease-Associated Autoantibodies as Surrogate Markers of Type 1 Diabetes in Young Children at Increased Genetic Risk
J. Clin. Endocrinol. Metab.,
March 1, 2000;
85(3):
1126 - 1132.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|